Manuscript
The Role of Adaptive and Innovative Trial Designs in Diabetes Research: A Scoping Review
Ashni Goshrani et al.
Diabetes Care 2025
Manuscript
Clinical perspectives of new insights and tools to minimize the hypoglycaemia burden connected with type 2 diabetes pharmacotherapy
Eberhard Standl et al.
Cardiovasc Diabetol. 2025;14:441
Manuscript
Estimating the risk of cardiovascular outcomes and all-cause mortality in individuals with type 2 diabetes: Validation of the UKPDS Outcomes Model using TECOS and EXSCEL data
Coleman RL et al.
Diabetes Obes Metab. 2025
Manuscript
International Variation in Case Fatality After Major Coronary or Cerebrovascular Events in Individuals With Type 2 Diabetes: Evidence From ADVANCE, TECOS, and EXSCEL
Philip M Clarke et al.
Diabetes Care 2025;48:1925-1931
Manuscript
Utilization of proteomic surrogates for early detection of unexpected drug benefits
Jessica Chadwick et al.
J Clin Pharmacol. 2025;65:1460-1473
Manuscript
Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysis
Ruth L Coleman et al.
Cardiovasc Diabetol. 2025;24:347